Literature DB >> 20926572

Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins.

Jungwook Hwang1, Luyun Huang, Daniel G Cordek, Robert Vaughan, Shelley L Reynolds, George Kihara, Kevin D Raney, C Cheng Kao, Craig E Cameron.   

Abstract

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) exhibits a preference for G/U-rich RNA in vitro. Biological analysis of the NS5A RNA-binding activity and its target sites in the genome will be facilitated by a description of the NS5A-RNA complex. We demonstrate that the C-4 carbonyl of the uracil base and, by inference, the C-6 carbonyl of the guanine base interact with NS5A. U-rich RNA of 5 to 6 nucleotides (nt) is sufficient for high-affinity binding to NS5A. The minimal RNA-binding domain of NS5A consists of residues 2005 to 2221 (referred to as domain I-plus). This region of the protein includes the amino-terminal domain I as well as the subsequent linker that separates domains I and II. This linker region is the site of adaptive mutations. U-rich RNA-binding activity is not observed for an NS5A derivative containing only residues 2194 to 2419 (domains II and III). Mass spectrometric analysis of an NS5A-poly(rU) complex identified domains I and II as sites for interaction with RNA. Dimerization of NS5A was demonstrated by glutaraldehyde cross-linking. This dimerization is likely mediated by domain I-plus, as dimers of this protein are trapped by cross-linking. Dimers of the domain II-III protein are not observed. The monomer-dimer equilibrium of NS5A shifts in favor of dimer when U-rich RNA is present but not when A-rich RNA is present, consistent with an NS5A dimer being the RNA-binding-competent form of the protein. These data provide a molecular perspective of the NS5A-RNA complex and suggest possible mechanisms for regulation of HCV and cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926572      PMCID: PMC3004340          DOI: 10.1128/JVI.01319-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.

Authors:  José Manuel Pérez Cañadillas; Gabriele Varani
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Young-Chan Kim; William K Russell; C T Ranjith-Kumar; Michael Thomson; David H Russell; C Cheng Kao
Journal:  J Biol Chem       Date:  2005-09-14       Impact factor: 5.157

3.  Brome mosaic virus capsid protein regulates accumulation of viral replication proteins by binding to the replicase assembly RNA element.

Authors:  Guanghui Yi; Ester Letteney; Chul-Hyun Kim; C Cheng Kao
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

4.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.

Authors:  Y Tanji; T Kaneko; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  The NS5A protein of hepatitis C virus is a zinc metalloprotein.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Alexander E Gorbalenya; Charles M Rice
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

6.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Charles M Rice
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

7.  All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding.

Authors:  Toshana L Foster; Tamara Belyaeva; Nicola J Stonehouse; Arwen R Pearson; Mark Harris
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  The alpha isoform of protein kinase CKI is responsible for hepatitis C virus NS5A hyperphosphorylation.

Authors:  Manuela Quintavalle; Sonia Sambucini; Chiara Di Pietro; Raffaele De Francesco; Petra Neddermann
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

9.  Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

Authors:  Min Gao; Richard E Nettles; Makonen Belema; Lawrence B Snyder; Van N Nguyen; Robert A Fridell; Michael H Serrano-Wu; David R Langley; Jin-Hua Sun; Donald R O'Boyle; Julie A Lemm; Chunfu Wang; Jay O Knipe; Caly Chien; Richard J Colonno; Dennis M Grasela; Nicholas A Meanwell; Lawrence G Hamann
Journal:  Nature       Date:  2010-04-21       Impact factor: 49.962

Review 10.  Hepatitis C virus NS5A: tales of a promiscuous protein.

Authors:  Andrew Macdonald; Mark Harris
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more
  39 in total

1.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.

Authors:  Daniel G Cordek; Tayler J Croom-Perez; Jungwook Hwang; Michele R S Hargittai; Chennareddy V Subba-Reddy; Qingxia Han; Maria Fernanda Lodeiro; Gang Ning; Thomas S McCrory; Jamie J Arnold; Hasan Koc; Brett D Lindenbach; Scott A Showalter; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-07-16       Impact factor: 5.157

3.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

4.  Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.

Authors:  Anita Nag; Jason M Robotham; Hengli Tang
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Correlation between NS5A dimerization and hepatitis C virus replication.

Authors:  Precious J Lim; Udayan Chatterji; Daniel Cordek; Suresh D Sharma; Jose A Garcia-Rivera; Craig E Cameron; Kai Lin; Paul Targett-Adams; Philippe A Gallay
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

6.  A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.

Authors:  Henry Grisé; Stephen Frausto; Timothy Logan; Hengli Tang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Serine 229 Balances the Hepatitis C Virus Nonstructural Protein NS5A between Hypo- and Hyperphosphorylated States.

Authors:  Chia-Ni Tsai; Ting-Chun Pan; Cho-Han Chiang; Chun-Chiao Yu; Shih-Han Su; Ming-Jiun Yu
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner.

Authors:  Toshana L Foster; Philippe Gallay; Nicola J Stonehouse; Mark Harris
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

9.  The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts.

Authors:  Liang Guo; Suresh D Sharma; Jose D Debes; Daniel Beisang; Bernd Rattenbacher; Irina Vlasova-St Louis; Darin L Wiesner; Craig E Cameron; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

10.  Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action.

Authors:  Paul Targett-Adams; Emily J S Graham; Jenny Middleton; Amy Palmer; Stephen M Shaw; Helen Lavender; Philip Brain; Thien Duc Tran; Lyn H Jones; Florian Wakenhut; Blanda Stammen; David Pryde; Chris Pickford; Mike Westby
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.